RxSight
RXST
197 hedge funds and large institutions have $1.58B invested in RxSight in 2024 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 68 increasing their positions, 65 reducing their positions, and 15 closing their positions.
4,762% more call options, than puts
Call options by funds: $5.01M | Put options by funds: $103K
193% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 15
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
30% more capital invested
Capital invested by funds: $1.22B → $1.58B (+$361M)
17% more funds holding
Funds holding: 169 → 197 (+28)
5% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 65
1.48% less ownership
Funds ownership: 84.22% → 82.74% (-1.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$25.8M |
| 2 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
+$24.4M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$15M |
| 4 |
Renaissance Technologies
New York
|
+$7.71M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$7.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$50.1M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$24.5M |
| 3 |
JP Morgan Chase
New York
|
-$14M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.1M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$10M |
RXST Hedge Fund Activity: Q1 2024 in Review
197 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q1 2024, worth a combined $1.58B — up 30% from $1.22B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new RXST positions and 15 closed out — a net gain of 29 holders — while 68 added to existing stakes and 65 trimmed.
The largest buyer was Invesco, adding an estimated $25.8M. The largest seller was Morgan Stanley, cutting an estimated $50.1M.
- 197 institutional investors held RxSight (RXST) as of Q1 2024, up from 169 in Q4 2023.
- Funds reported $1.58B of RxSight stock for Q1 2024, up 30% quarter-over-quarter.
- 44 funds opened new RxSight positions in Q1 2024 and 15 closed out, a net change of +29 holders.
- The largest RxSight buyer in Q1 2024 was Invesco, an estimated $25.8M added.
- The largest RxSight seller in Q1 2024 was Morgan Stanley, an estimated $50.1M sold.
Based on aggregated 13F filings for Q1 2024.